Management of Skull Base Meningioma

Diagnostic Imaging

• Contrast‑enhanced MRI must be obtained within 2 weeks before any intervention to delineate tumor extent, neurovascular relationships, and peritumoral edema. 1
• Pre‑operative digital subtraction angiography with possible embolisation is recommended for very large skull‑base meningiomas to reduce intra‑operative blood loss, after careful risk assessment. 2
• Somatostatin‑receptor PET should be performed when conventional imaging cannot clarify tumor borders or when the diagnosis is uncertain, because of its high specificity for meningioma. 1

Clinical Assessment

• Baseline neurological examination must document cranial‑nerve function (e.g., CN II‑VI for cavernous‑sinus/parasellar lesions, CN VII‑VIII for cerebellopontine‑angle lesions), motor and sensory status, visual fields, and hearing. 3
• Signs of raised intracranial pressure (headache, vomiting, papilledema) should be sought. 1
• Evaluation for brain‑stem compression symptoms is required for posterior‑fossa or petro‑clival lesions. 1
• Seizure activity is present in up to 30 % of patients with meningioma and must be recorded. 3

Immediate Medical Management

• Administer dexamethasone to patients with neurological deficits to control peritumoral edema. 1
• Start antiepileptic medication in patients who have experienced seizures. 1
• Obtain urgent neurosurgical consultation for patients with significant neurological impairment or brain‑stem compression. 1

Multidisciplinary Planning

• A multidisciplinary team—including skull‑base‑experienced neurosurgeons, radiation oncologists, and, when appropriate, otolaryngologists—must evaluate each case before surgery. 2
• The operative goal is maximal safe resection (Simpson I–II when feasible); radical excision at any cost should be avoided. 4
• Image‑guided neuronavigation is strongly recommended for operative planning. 1

Expected Surgical Outcomes

Data derived from cohort studies and expert series. [5] [4]

Management of Asymptomatic Small Tumors (<30 mm)

• Observation is appropriate when the lesion is in an eloquent, deep, or brain‑stem region, or when the patient is elderly or has significant comorbidities. 4
• Surveillance MRI with contrast should be performed every 6–12 months. 4
• Surgery is indicated if serial imaging shows tumor growth, if the lesion becomes surgically accessible with acceptable risk, or in younger, healthier patients. 4

Adjuvant Radiotherapy

• External‑beam radiotherapy is indicated after resection of WHO Grade III (malignant) meningioma. 4
• For WHO Grade II (atypical) meningioma with subtotal resection, postoperative EBRT is recommended. 4
• Stereotactic radiosurgery may be used for tumors located in eloquent areas where surgery carries unacceptable risk. 4
• The first post‑radiotherapy MRI should be considered the new baseline for subsequent surveillance. 4

Advanced Systemic Options

• Peptide‑receptor radionuclide therapy (PRRT) with radiolabelled somatostatin‑receptor ligands shows promise for treatment‑refractory meningioma. 4
• Prior to PRRT, SSTR‑PET imaging must be performed to confirm target expression. 4

Post‑Treatment Surveillance

• WHO Grade I meningioma: contrast‑enhanced MRI every 6–12 months; recurrence can reach 20 % within 25 years even after complete resection.** 4
• WHO Grade II/III meningioma: more frequent imaging; SSTR‑PET may aid differentiation of recurrence from post‑treatment change.** 4

Special Populations

• Pediatric skull‑base meningioma: more likely to present with calcifications and cystic change; requires pediatric‑neurosurgical expertise and referral to specialized centers.** [1] [2]
• Large blood loss is of particular concern in children because of their lower total blood volume. 2

Key Pitfalls to Avoid

• Do not attempt radical excision at any cost; prioritize functional preservation.
• Do not underestimate intra‑operative blood loss—consider pre‑operative embolisation for large lesions. 2
• Do not overlook the necessity of referral to a skull‑base‑specialized neurosurgical team for complex locations. 2

All statements are supported by the cited references indicated in brackets.

Skull‑Base Meningioma Surgical Management Guidelines

Pre‑operative Planning

• Multidisciplinary evaluation—including neurosurgeons experienced in skull‑base surgery, radiation oncologists, and otolaryngologists when appropriate—is recommended for pediatric patients with cavernous sinus, petrous‑bone, or cerebellopontine‑angle meningiomas to optimize treatment strategy. 6
• For very large skull‑base meningiomas, pre‑operative digital subtraction angiography with possible embolization should be performed to reduce intra‑operative blood loss, a consideration that is especially important in children because of their lower total blood volume. 6

Location‑Specific Surgical Approaches

Cavernous‑Sinus Meningiomas

• The pterional craniotomy, with or without an orbito‑zygomatic osteotomy, is the most frequently employed approach for cavernous‑sinus lesions. [7][8]
• Gross‑total (Simpson I‑II) resection can be achieved in approximately 84 % of cavernous‑sinus meningiomas when the tumor originates from the interlayer between the lateral wall of the cavernous sinus and dura mater. 7
• Intra‑operative electrophysiological monitoring of the cranial nerves that traverse the cavernous sinus is recommended to minimize postoperative nerve deficits. 6

Petrous / Petroclival Region

• Management of meningiomas in the petrous or petroclival region requires surgeons with specialized skull‑base expertise due to the complex anatomy and proximity to critical neurovascular structures. 6

Surgical Goals and Extent of Resection

• The operative objective is maximal safe resection (Simpson I‑II when feasible); radical excision that jeopardizes neurovascular structures should be avoided. 6
• Complete resection that includes removal of the dural attachment offers the best long‑term tumor control, provided that neurovascular integrity is preserved. 6
• When the tumor encases vital structures such as the internal carotid artery or major venous sinuses, a planned subtotal resection followed by adjuvant stereotactic radiosurgery is the preferred strategy. 6

Intra‑operative Considerations

• Excessive blood loss is a major concern in pediatric patients because of the disproportionate impact on their total blood volume; strategies to mitigate this include pre‑operative embolization for large lesions. 6
• For extremely large hemispheric skull‑base meningiomas, pre‑operative embolization should be strongly considered to further limit intra‑operative hemorrhage. 6
• Tumors that envelop the carotid artery or venous sinuses may necessitate intentional subtotal resection to preserve vascular integrity. 6
• Intracavernous meningiomas exemplify cases where multidisciplinary discussion of surgical risk versus alternative therapies (e.g., radiosurgery) is essential for optimal decision‑making. 6

Post‑operative Surveillance

• Even after complete resection of a benign (WHO Grade I) skull‑base meningioma, recurrence can occur in up to 20 % of cases within 25 years, underscoring the need for lifelong imaging follow‑up. 9